Lannett Co Inc

NYSE: LCIHealthcare / Drugs - Generic / USA
11.46-0.2700-2.30%Vol 281 3411Y Perf 195.09%
Oct 21st, 2019 11:59
BID11.46 ASK11.48
Open11.65 Previous Close11.73
Pre-Market11.70 After-Trading11.73
 -0.03 -0.26%  - -%
Target Price
12.50 
Analyst Rating
Hold 3.00
Potencial %
9.84 
Finscreener Ranking
★★+     47.76
Insiders Trans % 3/6/12M
-/60/79 
Value Ranking
★+     43.36
Insiders Value % 3/6/12M
-10/34/60 
Growth Ranking
     32.93
Insiders Shares Cnt. % 3/6/12M
-1/51/74 
Income Ranking
 —    -
Market Cap (mil)463 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
66.69 
Earnings Date
6th Nov 2019

Today's Price Range

11.3111.81

52wk Range

3.3315.52

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
6.06%
1 Month
-12.53%
3 Months
96.15%
6 Months
64.06%
1 Year
195.09%
3 Years
-48.10%
5 Years
-72.85%
10 Years
49.05%

Name / TickerPriceChg.Chg.%
LCI11.46-0.2700-2.30
AAPL240.704.29001.81
GOOG1 245.540.05000.00
MSFT137.440.03000.02
XOM68.621.01001.49
WFC50.440.47000.94
JNJ127.60-0.1000-0.08
FB189.033.18001.71
GE8.84-0.1200-1.34
JPM123.222.66002.21
Earnings HistoryEstimateReportedSurprise %
Q04 20190.210.3776.19
Q03 20190.620.689.68
Q02 20190.680.8626.47
Q01 20190.400.4410.00
Q04 20180.640.640.00
Q03 20180.760.805.26
Q02 20180.861.0623.26
Q01 20180.520.6015.38
Earnings Per EndEstimateRevision %Trend
9/2019 QR0.2081.82Positive
12/2019 QR0.3057.89Positive
6/2020 FY1.2526.26Positive
6/2021 FY1.6721.90Positive
Next Report Date6th Nov 2019
Estimated EPS Next Report0.20
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume281 341
Shares Outstanding (in ths.)40 406
Trades Count1 315
Dollar Volume2 758 009
Avg. Volume1 608 757
Avg. Weekly Volume725 138
Avg. Monthly Volume1 203 229
Avg. Quarterly Volume2 282 926
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (100.00 %)
3 (100.00 %)
5 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

Lannett Co Inc

Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.

CEO:

Teplephone: +1 215 333-9000

Address: 9000 State Road, Philadelphia 19136, PA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

63%38%

Bearish Bullish

68%32%

News